Comparison of the effects of two preparations of insulin in NIDDM patients with secondary sulphonylurea failure

被引：0
|
作者：
Wang, DQ [1 ]
Xu, L [1 ]
Ren, JM [1 ]
Chen, YL [1 ]
机构：
[1] HOSP SHANDONG MED UNIV,JINAN,PEOPLES R CHINA
来源：
DIABETOLOGIA | 1997年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1335 / 1335
页数：1
相关论文
共 50 条
  • [21] Comparison of different insulin regimens in elderly patients with NIDDM
    Wolffenbuttel, BHR
    Sels, JPJE
    RondasColbers, GJWM
    Menheere, PPCA
    Kruseman, ACN
    DIABETES CARE, 1996, 19 (12) : 1326 - 1332
  • [22] Insulin analogue therapy in Korean type 2 diabetic patients with secondary sulphonylurea failure: Insulin analogue strategy based on clinical and biochemical variables
    Lee, Byung-Wan
    Lee, Hae-Ri
    Kim, Chul-Shik
    Kim, Doo-Man
    Yu, Jae-Myung
    Ihm, Yusung-Hee
    Choi, Moon-Gi
    Yoo, Hyung-Joon
    DIABETES, 2008, 57 : A578 - A578
  • [23] Obese NIDDM patients show a progressive increase of insulin resistance that causes secondary failure of oral agents.
    Pontiroli, AE
    Piatti, PM
    Pacchioni, M
    Camisasca, R
    DIABETOLOGIA, 1997, 40 : 1336 - 1336
  • [24] Repaglinide versus sulphonylurea in combination with bedtime NPH insulin in patients with Type 2 diabetes with secondary failure to oral treatment.
    Strojek, K
    Polaszewska-Muszynska, M
    Krassowski, J
    Gumprecht, J
    Rudzki, H
    Olejniczak, H
    Nazar, M
    DIABETOLOGIA, 2003, 46 : A282 - A282
  • [25] Secondary failure in non-insulin-dependent diabetes mellitus (NIDDM): Effect of insulin on renal function
    Chattington, PD
    Hampson, K
    Purewal, TS
    Jones, IR
    Vora, JP
    DIABETOLOGIA, 1997, 40 : 2135 - 2135
  • [26] COMPARISON OF BASAL AND PRANDIAL INSULIN THERAPY IN PATIENTS WITH SECONDARY FAILURE OF SULFONYLUREA THERAPY
    PATERSON, KR
    WILSON, M
    KESSON, CM
    BUCHAN, M
    ROBERTS, M
    REITH, SBM
    DAVIDSON, E
    DIABETIC MEDICINE, 1991, 8 (01) : 40 - 43
  • [27] C-peptide evolution in NIDDM patients treated with lispro insulin for secondary failure to oral hypoglycemic agents.
    Gonzalo, MA
    DelPeso, C
    SanchezVilar, O
    Azriel, S
    Lara, J
    Rovira, A
    HerreraPombo, JL
    DIABETOLOGIA, 1997, 40 : 1373 - 1373
  • [28] The usefulness of combination on therapy with insulin injection and alpha-glucosidase inhibitor in NIDDM patients with secondary failure on sulfonylureas agents
    Kanda, T
    Imano, E
    Yamazaki, Y
    Kawamori, R
    DIABETOLOGIA, 1997, 40 : 1253 - 1253
  • [29] ALTERNATE DAY SULFONYLUREA THERAPY (ADS) - METABOLIC EFFECTS IN NIDDM PATIENTS WITH SECONDARY SULFONYLUREA (SSU) FAILURE
    COTTRELL, DA
    OSEI, K
    CLINICAL RESEARCH, 1991, 39 (02): : A446 - A446
  • [30] Effects of fatty acids on insulin secretion in patients with NIDDM.
    Chen, XH
    Boden, G
    DIABETES, 1996, 45 : 1161 - 1161
12345